Cycloset, a new form of bromocriptine for type 2 diabetes

February 2011

Reps are promoting Cycloset, a new form of bromocriptine for type 2 diabetes.

That's right...diabetes. We usually think of bromocriptine as a dopamine agonist for Parkinson's...or to lower prolactin levels.

But it can also lower blood glucose...a little.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Psychiatry you'll have more options to help patients get a suitable atypical antipsychotic
Infectious Diseases New guidelines for treating methicillin-resistant S. aureus (MRSA) will change treatment of community-acquired skin infections
Neurology & Pain Prescription combo analgesics will be limited to only 325 mg of acetaminophen per tab or cap
Neurology & Pain Butrans (BYOO-trans), a new once-a-week C-III buprenorphine patch for chronic pain
Diabetes Cycloset, a new form of bromocriptine for type 2 diabetes
Cardiology questions about the safety of Multaq (dronedarone) for atrial fibrillation
Osteoporosis Atelvia (uh-TEL-vee-uh), a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis
ADHD Kapvay (clonidine extended-release) for attention deficit hyperactivity disorder (ADHD) in children
Antidepressants confusion about generics for bupropion (Wellbutrin, Zyban, Budeprion, Buproban, etc)
Poison Prevention drugs that are toxic in young children
Vaccines CDC now recommends giving pertussis vaccine (Tdap) to SENIORS